Pill Identifier Rinvoq - NDC 0074-2306
Upadacitinib
Product Code 0074-2306
Rinvoq by Abbvie Inc. is a purple oval tablet extended release about 14 mm in size, imprinted with a15. The product is a human prescription drug with active ingredient(s) upadacitinib.
Rinvoq
Active Ingredient(s): Upadacitinib
Inactive Ingredient(s):
- MICROCRYSTALLINE CELLULOSE
- HYPROMELLOSE, UNSPECIFIED
- MANNITOL
- TARTARIC ACID
- SILICON DIOXIDE
- MAGNESIUM STEARATE
- POLYVINYL ALCOHOL, UNSPECIFIED
- POLYETHYLENE GLYCOL, UNSPECIFIED
- TALC
- TITANIUM DIOXIDE
- FERROSOFERRIC OXIDE
- FERRIC OXIDE RED
Abbvie Inc.
Product Type: Human Prescription Drug
Dosage Form: Tablet, Extended Release
- Purple (C48327)
Product Packages
NDC Package Code | Package Description |
---|---|
0074-2306-30 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE |
0074-2306-70 | 14 TABLET, EXTENDED RELEASE in 1 BOTTLE |
* Please review the disclaimer below.
Pill Identification data last updated on: December, 2018
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product. If this is an emergency, call 911 or the national Poison Help hotline at 1-800-222-1222. Most images are not part of the product labels and have not been verified by the labeler company. ALWAYS consult your physician or pharmacist with any medication-related questions.